ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Grifols SA

Grifols SA (GRFS)

7,86
0,13
(1,68%)
À la fermeture: 07 Janvier 10:00PM
7,86
-0,005
( -0,06% )
Après les heures de négociation: 12:00AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
7,86
Prix Achat
7,41
Prix Vente
7,99
Volume échangé
683 207
7,66 Fourchette du Jour 7,94
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
7,73
Ouverture
7,6801
Dernière Transaction
68459
@
7.86
(average)
Dernière heure de transaction
22:27:29
Volume financier
US$ 5 341 890
VWAP
7,8188
Volume moyen (3 m)
-
Actions en circulation
687 554 908
Rendement du Dividende
-
Ratio Cours sur Bénéfices
110,66
Bénéfice par action (BPA)
0,09
Chiffre d'affairess
6,59B
Bénéfice net
59,32M

À propos de Grifols SA

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine we develop produce and provide innovative healthcare services and solutions in mo... Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine we develop produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic rare and prevalent diseases sometimes life-threatening drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology hepatology and intensive care pulmonology hematology neurology and infectious diseases. With a workforce of over 27000 employees in more than 30 countries and regions we are committed to a sustainable business model that sets the standard for continuous innovation quality safety and ethical leadership in the industry. Show more

Secteur
Medicinal Chems,botanicl Pds
Industrie
In Vitro,in Vivo Diagnostics
Site Web
Siège social
Barcelona, Catalonia, Esp
Fondé
1987
Grifols SA est coté dans le secteur Medicinal Chems,botanicl Pds de la NASDAQ avec le ticker GRFS. Le dernier cours de clôture d'Grifols était de US$7,73. Au cours de la dernière année, les actions de Grifols ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Grifols compte actuellement 687 554 908 actions en circulation. La capitalisation boursière d'Grifols est de US$5,31 milliard. Grifols a un ratio cours/bénéfice (ratio PE) de 110.66.

GRFS Dernières nouvelles

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

SAN CARLOS, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and...

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasisGrifols surgical bleeding management...

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur mustard, a chemical warfare...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

GRFS - Frequently Asked Questions (FAQ)

What is the current Grifols share price?
The current share price of Grifols is US$ 7,86
How many Grifols shares are in issue?
Grifols has 687 554 908 shares in issue
What is the market cap of Grifols?
The market capitalisation of Grifols is USD 5,31B
What is the 1 year trading range for Grifols share price?
Grifols has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Grifols?
The price to earnings ratio of Grifols is 110,66
What is the cash to sales ratio of Grifols?
The cash to sales ratio of Grifols is 1
What is the reporting currency for Grifols?
Grifols reports financial results in EUR
What is the latest annual turnover for Grifols?
The latest annual turnover of Grifols is EUR 6,59B
What is the latest annual profit for Grifols?
The latest annual profit of Grifols is EUR 59,32M
What is the registered address of Grifols?
The registered address for Grifols is CALLE JESUS I MARIA, 6, BARCELONA, CATALONIA, 08174
What is the Grifols website address?
The website address for Grifols is www.grifols.com
Which industry sector does Grifols operate in?
Grifols operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MSAIMultiSensor AI Holdings Inc
US$ 2,765
(38,25%)
2,47M
MCVTMill City Ventures III Ltd
US$ 3,06
(35,40%)
58,27k
QRTEBQurate Retail Inc
US$ 3,13
(22,27%)
103
NARIInari Medical Inc
US$ 78,80
(21,23%)
4,69M
XTIAXTI Aerospace Inc
US$ 0,1021
(16,02%)
351,58M
ENVBEnveric Biosciences Inc
US$ 0,3501
(-17,14%)
320,83k
AMSTAmesite Inc
US$ 3,38
(-16,54%)
59,83k
GDTCCytoMed Therapeutics Ltd
US$ 2,90
(-15,45%)
61,49k
SLRNACELYRIN Inc
US$ 2,98
(-14,61%)
499,8k
ACXPAcurx Pharmaceuticals Inc
US$ 0,9599
(-11,94%)
163,31k
XTIAXTI Aerospace Inc
US$ 0,1021
(16,02%)
351,58M
SVMHSRIVARU Holding Ltd
US$ 0,0519
(12,10%)
29,26M
CRKNCrown Electrokinetics Corporation
US$ 0,143
(7,52%)
24,61M
CDTConduit Pharmaceuticals Inc
US$ 0,0829
(14,66%)
16,57M
CEROCERo Therapeutics Holdings Inc
US$ 0,0469
(10,87%)
16,42M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock